Institutional Affairs



Professor CHAN Tak Cheung, Anthony

Institutional Affairs - Associate Dean

Li Shu Fan Professor of Clinical Oncology
Chief of Service, Department of Clinical Oncology, Prince of Wales Hospital
Director, Sir YK Pao Centre for Cancer, Prince of Wales Hospital
Director, Hong Kong Cancer Institute
Professor (by courtesy), School of Biomedical Sciences
Cluster Coordinator in Clinical Oncology, New Territories East Cluster
Associate Director, State Key Laboratory of Oncology in South China (Partner laboratory of CUHK)
College Master, Wu Yee Sun College

Institutional Affairs - Associate Dean

Professor CHAN Tak Cheung, Anthony

Department of Clinical Oncology

Contact Information
Office : (852) 3505-2119
Email : anthonytcchan@cuhk.edu.hk


School / Department / Institute / Centre / Unit
Department of Clinical Oncology

Expertise
Cancers with a high prevalence rate in Asia, particularly nasopharynx cancer (as evidenced by publication of over 280 peer-reviewed articles on integrated, multi-modality treatment, novel therapeutics and molecular markers in Asian cancers)

Education
1988 University College & Middlesex Joint School of Medicine,
University of London, UK
MB, BS
1998 MD, CUHK
1992 Member of Royal College of Physicians (UK)
1996 Fellow of Hong Kong College of Physicians (Specialist in Medical Oncology)
1996 Fellow of Hong Kong Academy of Medicine (Medicine)
2001 Fellow of Royal College of Physicians (Edinburgh)
2004 Fellow of Royal College of Physicians (London)
2008 Fellow of Royal College of Physicians (Glasgow)


Research Interests
Nasopharyngeal Carcinoma, Colorectal Cancer, Hepatocellular Carcinoma
部份论文
 
  1. Chan A.T.C., Hui E.P., Ngan R.K.C., Tung S.Y., Cheng A.C.K., Ng W.T., Lee V.H.F., Ma B.B.Y., Cheng H.C., Wong F.C.S., Loong H.H.F., Tong M., Poon D.M.C., Ahuja A.T., King A.D., Wang K., Mo F., Zee B. C.Y., Chan K.C.A., Lo Y.M.D. Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial. J Clin Oncol. 2018 Epub Jul 10.
  2. Ma B.B.Y., Lim W.T., Goh B.C., Hui E.P., Lo K.W., Pettinger A., Foster N.R., Riess J.W., Agulnik M., Chang A.Y.C., Chopra A., Kish J.A., Chung C.H., Adkins D.R., Cullen K.J., Gitlitz B.J., Lim D.W., To K.F., Chan K.C.A., Lo Y.M.D., King A.D., Erlichman C., Yin J., Costello B.A., Chan A.T.C. Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742). J Clin Oncol. 2018 May 10;36(14):1412-1418. Epub 2018 Mar 27.
  3. Chua M.L.K., Wee J.T.S., Hui E.P., Chan A.T.C. Nasopharyngeal carcinoma. Lancet. 387(10022):1012-24. Epub 2015 Aug 28.
  4. Lee A.W.M, Ma B.B.Y., Ng W.T., Chan A.T.C. The management of nasopharyngeal carcinoma – current practice and future perspective. J Clin Oncol  10;33(29):3356-64. Epub 2015 Sep 8.
  5. Hui E.P., Taylor G.S., Hui J., Ma B.B.Y., Chan S.L., Ho R., Wong W.L., Wilson St., Johnson B.F., Edwards C., Stocken D.D., Rickinson A.B., Steven N.M., Chan A.T.C. Phase 1 trial of recombinant Modified Vaccinia Ankara encoding EBV-encoded tumor antigens in nasopharyngeal carcinoma patients. Cancer Research 13;73:1676-88.
  6. Hui E.P., Ma B.B.Y., Leung S.F., King A.D., Mo F., Kam M.K.M., Yu B.K.H., Chiu S.K.W., Kwan W.H., Ho R., Chan I., Ahuja A.T., Zee B.C.Y., Chan A.T.C. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant chemotherapy using docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol 09;27:242-9.
  7. Wee J.T., Anderson B.O., Corry J., D’Cruz A., Soo K.C., Qian C.N., Chua D.T., Hicks R.J., Goh C.H., Khoo J.B., Ong S.C., Forastiere A.A., Chan A.T.C. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009.    Lancet Oncol 09;10:1086-92.
  8. Kam M.M.K., Leung S.F., Zee B.C.Y., Chau R.M.C., Suen J.J.S., Mo F., Lai M., Ho R., Cheung K.Y., Yu B.K.H., Chiu S.K.W., Choi P.H.K., Teo P.M.L., Kwan W.H., Chan A.T.C. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.  J Clin Oncol 07;25:4873-9.         
  9. Leung S.F., Zee B.C.Y., Ma B.B.Y., Hui E.P., Mo F., Lai M., Chan A.K.C., Chan L.Y.S., Kwan W.H., Lo Y.M.D., Chan A.T.C. Combined clinical- biomolecular staging for cancer: the model of nasopharyngeal cancer. J Clin Oncol 06;24:5414-8.
  10. Chan A.T.C., Hsu M.M., Goh B.C., Hui E.P., Liu T.W., Millward M.J., Chang A.Y.C., Hong R.L., Whang-Peng J., Ma B.B.Y., Mueser M., Amellal N., Lin X. A multi-center, phase II study of Cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol 05;23:3568-76.
  11. Chan A.T.C., Leung S.F., Ngan R.K.C., Teo P.M.L., Lau W.H., Kwan W.H., Hui E.P., Cheung F.Y., Yeo W., Yiu H.H., Yu K.H., Chiu K.W., Chan D.T., Mok T.S.K., Yuen K.T., Mo F.K.F., Lai M.M.P., Ma B.B.Y., Johnson P.J., Zee B.C.Y. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 05;97:536-9.
  12. Chan A.T.C., Tao Q., Robertson K.D., Flinn I.W., Mann R.B., Klenck B., Kwan W.H., Leung WT., Johnson P.J., Ambinder R.F. Azacytidine induces demethylation of the Epstein-Barr virus genome in tumors in patients. J Clin Oncol 04;22:1373-81.
Division of Medical Sciences – Oncology